These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38072809)

  • 1. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism.
    Billingsley MM; Gong N; Mukalel AJ; Thatte AS; El-Mayta R; Patel SK; Metzloff AE; Swingle KL; Han X; Xue L; Hamilton AG; Safford HC; Alameh MG; Papp TE; Parhiz H; Weissman D; Mitchell MJ
    Small; 2024 Mar; 20(11):e2304378. PubMed ID: 38072809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
    Billingsley MM; Singh N; Ravikumar P; Zhang R; June CH; Mitchell MJ
    Nano Lett; 2020 Mar; 20(3):1578-1589. PubMed ID: 31951421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta.
    Geisler HC; Ghalsasi AA; Safford HC; Swingle KL; Thatte AS; Mukalel AJ; Gong N; Hamilton AG; Han EL; Nachod BE; Padilla MS; Mitchell MJ
    J Control Release; 2024 Jul; 371():455-469. PubMed ID: 38789090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells.
    Billingsley MM; Hamilton AG; Mai D; Patel SK; Swingle KL; Sheppard NC; June CH; Mitchell MJ
    Nano Lett; 2022 Jan; 22(1):533-542. PubMed ID: 34669421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells.
    Prazeres PHDM; Ferreira H; Costa PAC; da Silva W; Alves MT; Padilla M; Thatte A; Santos AK; Lobo AO; Sabino A; Del Puerto HL; Mitchell MJ; Guimaraes PPG
    Int J Nanomedicine; 2023; 18():5891-5904. PubMed ID: 37873551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy.
    Soroudi S; Jaafari MR; Arabi L
    J Control Release; 2024 Aug; 372():113-140. PubMed ID: 38876358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery.
    Ye Z; Chen J; Zhao X; Li Y; Harmon J; Huang C; Chen J; Xu Q
    ACS Biomater Sci Eng; 2022 Feb; 8(2):722-733. PubMed ID: 35104103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
    Patel SK; Billingsley MM; Mukalel AJ; Thatte AS; Hamilton AG; Gong N; El-Mayta R; Safford HC; Merolle M; Mitchell MJ
    Theranostics; 2024; 14(1):1-16. PubMed ID: 38164140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAR T cells produced in vivo to treat cardiac injury.
    Rurik JG; Tombácz I; Yadegari A; Méndez Fernández PO; Shewale SV; Li L; Kimura T; Soliman OY; Papp TE; Tam YK; Mui BL; Albelda SM; Puré E; June CH; Aghajanian H; Weissman D; Parhiz H; Epstein JA
    Science; 2022 Jan; 375(6576):91-96. PubMed ID: 34990237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy.
    Metzloff AE; Padilla MS; Gong N; Billingsley MM; Han X; Merolle M; Mai D; Figueroa-Espada CG; Thatte AS; Haley RM; Mukalel AJ; Hamilton AG; Alameh MG; Weissman D; Sheppard NC; June CH; Mitchell MJ
    Adv Mater; 2024 Jun; 36(26):e2313226. PubMed ID: 38419362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering.
    Hamilton AG; Swingle KL; Joseph RA; Mai D; Gong N; Billingsley MM; Alameh MG; Weissman D; Sheppard NC; June CH; Mitchell MJ
    Adv Healthc Mater; 2023 Dec; 12(30):e2301515. PubMed ID: 37602495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo.
    Golubovskaya V; Sienkiewicz J; Sun J; Zhang S; Huang Y; Zhou H; Harto H; Xu S; Berahovich R; Wu L
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering.
    Kitte R; Rabel M; Geczy R; Park S; Fricke S; Koehl U; Tretbar US
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101139. PubMed ID: 38027056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo.
    Zhou JE; Sun L; Jia Y; Wang Z; Luo T; Tan J; Fang X; Zhu H; Wang J; Yu L; Yan Z
    J Control Release; 2022 Oct; 350():298-307. PubMed ID: 36002054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma.
    Álvarez-Benedicto E; Tian Z; Chatterjee S; Orlando D; Kim M; Guerrero ED; Wang X; Siegwart DJ
    Angew Chem Int Ed Engl; 2023 Oct; 62(44):e202310395. PubMed ID: 37651468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.
    Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based Nanoparticles.
    Giulimondi F; Digiacomo L; Renzi S; Cassone C; Pirrottina A; Molfetta R; Palamà IE; Maiorano G; Gigli G; Amenitsch H; Pozzi D; Zingoni A; Caracciolo G
    ACS Appl Bio Mater; 2024 Jun; 7(6):3746-3757. PubMed ID: 38775109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research advance in lipid nanoparticle-mRNA delivery system and its application in CAR-T cell therapy.
    Ye B; Hu Y; Zhang M; Huang H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):185-191. PubMed ID: 36161298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
    Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
    Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.